放射線災害医療学研究分野
論文
A 欧文A-a
1. Zhang W, Ohira T, Abe M, Kamiya K, Yamashita S, Yasumura S, Ohtsuru A, Masaharu M, Harigane M, Horikoshi N, Suzuki Y,Yabe H, Yuuki M, Nagai M, Takahashi H, Nakano H; Fukushima Health Management Survey Group: Evacuation after the Great
East Japan Earthquake was associated with poor dietary intake: The Fukushima Health Management Survey. J Epidemiol 27(1):14-23, 2017. (IF: 2.447) ＊2. Saenko VA, Thomas GA, Yamashita S: Meeting report: the 5th International expert symposium in Fukushima on radiation andhealth. Environ Health 16(1): 3, 2017. (IF: 3.816) ＊3. Yoshida K, Krille L, Dreger S, Hoenig L, Merzenich H, Yasui K, Kumagai A, Ohtsuru A, Uetani M, Mildenberger P, Takamura
N, Yamashita S, Zeeb H, Kudo T: Pediatric computed tomography practice in Japanese university hospital from 2008-2010: did
it differ from German practice? J Radiat Res 58(1): 135-141, 2017. (IF: 1.788) ＊4. Nikitski A, Rogounovitch T, Bychkov A, Takahashi M, Yoshiura KI, Mitsutake N, Kawaguchi T, Matsuse M, Drozd VM,Demidchik YE, Nishihara E, Hirokawa M, Miyauchi A, Rubanovitch AV, Matsuda F, Yamashita S, Saenko VA: Genotypeanalyses in the Japanese and Belarusian populations reveal independent effects of rs965513 and rs1867277 but do not support therole of FOXE1 polyalanine tract length in conferring risk for papillary thyroid carcinoma. Thyroid 27(2): 224-235, 2017. (IF:5.515) ＊◇5. Matsuse M, Yabuta T, Saenko V, Hirokawa M, Nishihara E, Suzuki K, Yamashita S, Miyauchi A, Mitsutake N: TERT promotermutations and Ki-67 labeling index as a prognostic marker of papillary thyroid carcinomas: combination of two independentfactors. Sci Rep 7: 41752, 2017. (IF: 4.259) ＊◇6. Yamauchi M, Shibata A, Suzuki K, Suzuki M, Niimi A, Kondo H, Miura M, Hirakawa M, Tsujita K, Yamashita S, Matsuda N:
Regulation of pairing between broken DNA-containing chromatin regions by Ku80, DNA-PKcs, ATM, and 53BP1. Sci Rep 7:41812, 2017. (IF: 4.259) ＊7. Hashimoto S, Nagai M, Fukuma S, Ohira T, Hosoya M, Yasumura S, Satoh H, Suzuki H, Sakai A, Ohtsuru A, Kawasaki Y,Takahashi A, Ozasa K, Kobashi G, Kamiya K, Yamashita S, Fukuhara SI, Ohto H, Abe M; Fukushima Health Management
Survey Group: Influence of Post-disaster Evacuation on Incidence of Metabolic Syndrome. J Atheroscler Thromb 24(3): 327-337,
2017. (IF: 2.442) ＊8. Shimamura M, Kurashige T, Mitsutake N, Nagayama Y: Aldehyde dehydrogenase activity plays no functional role in stem
cell-like properties in anaplastic thyroid cancer cell lines. Endocrine 55(3): 934-943, 2017. (IF: 3.131) ＊9. Yasui K, Kimura Y, Kamiya K, Miyatani R, Tsuyama N, Sakai A, Yoshida K, Yamashita S, Chhem R, Abdel-Wahab M,Ohtsuru A: Academic Responses to Fukushima Disaster. Asia Pac J Public Health 29(2_suppl): 99S-109S, 2017. (IF: 0.811) ＊10. Takahashi A, Ohira T, Hosoya M, Yasumura S, Nagai M, Ohira H, Hashimoto S, Satoh H, Sakai A, Ohtsuru A, Kawasaki Y,Suzuki H, Kobashi G, Ozasa K, Yamashita S, Kamiya K, Abe M; Fukushima Health Management Survey Group.: Effect ofevacuation on liver function after the Fukushima Daiichi Nuclear Power Plant accident: The Fukushima Health ManagementSurvey. J Epidemiol 27(4): 180-185, 2017. (IF: 2.447) ＊11. Yamashita S, Saenko VA: What is the “Screening Effect” Six years after the Fukushima Nuclear Power Plant Accident? Thyroid
27(5): 595-596, 2017. (IF: 5.515) ＊12. Iyama K, Matsuse M, Mitutake N, Rogounovitch T, Saenko VA, Suzuki K, Ashizawa M, Ookouchi C, Suzuki S, Mizunuma H,Fukushima T, Suzuki S, Yamashita S: Identification of three novel fusion oncogenes, SQSTM1/NTRK3, AFAP1L2/RET, andPPFIBP2/RET in thyroid cancers of young patients in Fukushima. Thyroid 27(6): 811-818, 2017. (IF: 5.515) ＊○◇13. Orita M, Fukushima Y, Yamashita S, Takamura N: The Need for Forest Decontamination; For the Recovery of Fukushima.
Radiat Prot Dosimetry 175(2): 295-296, 2017. (IF: 0.917) ＊14. Zhang W, Ohira T, Yasumura S, Maeda M, Ohtsuru A, Harigane M, Horikoshi N, Suzuki Y, Yabe H, Nagai M, Nakano H,Hirosaki M, Uemura M, Takahashi H, Kamiya K, Yamashita S, Abe M; Fukushima Health Management Survey Group: Effects
of socioeconomic factors on cardiovascular- related symptoms among residents in Fukushima after the Great East Japan
Earthquake: a cross-sectional study using data from the Fukushima Health Management Survey. BMJ Open 7(6): e014077, 2017.
(IF: 2.369) ＊15. Orita M, Nakashima K, Taira Y, Fukuda T, Fukushima Y, Kudo T, Endo Y, Yamashita S, Takamura N: Radiocesium
concentrations in wild mushrooms after the accident at the Fukushima Daiichi Nuclear Power Station; Follow-up study inKawauchi village. Sci Rep 7(1): 6744, 2017. (IF: 4.259) ＊16. Suzuki S, Midorikawa S, Matsuzuka T, Fukushima T, Ito Y, Shimura H, Takahashi H, Ohira T, Ohtsuru A, Abe M, Suzuki S,Yamashita S: Prevalence and characterization of thyroid hemiagenesis in Japan: The Fukushima Health Management Survey.

1Thyroid 27(8): 1011-1016, 2017. (IF: 5.515) ＊17. Khvostunov I.K., Saenko V.A., Krylov V., Rodichev A., Yamashita S: Cytogenetic biodosimetry and dose-rate effect afterradioiodine therapy for thyroid cancer. Radiat Environ Biophys 56(3): 213-226, 2017. (IF: 2.398) ＊18. Doi R, Tsuchiya T, Mitsutake N, Nishimura S, Matsuu-Matsuyama M, Nakazawa Y, Ogi T, Akita S, Yukawa H, Baba Y,Yamasaki N, Matsumoto K, Miyazaki T, Kamohara R, Hatachi G, Sengyoku H, Watanabe H, Obata T, Niklason LE, Nagayasu
T: Transplantation of bioengineered rat lungs recellularized with endothelial and adipose-derived stromal cells. Sci Rep 7(1):8447, 2017. (IF: 4.259) ＊★
19. Yabuta T, Matsuse M, Hirokawa M, Yamashita S, Mitsutake N, Miyaushi A: TERT promoter mutations were not found inpapillary thyroid microcarcinomas that showed disease progression on active surveillance. Thyroid 27(9): 1206-1207, 2017. (IF:5.515) ＊◇20. Hirokawa M, Miyauchi A, Kihara M, Kudo T, Hashimoto Y, Suzuki S, Daa T, Vuong HG, Mitsutake N: Chromophobe renal cell
carcinoma-like thyroid carcinoma: A novel clinicpathologic entity possibly associated with tuberous sclerosis complex. Endocr J64(9): 843-850, 2017 (IF: 1.837) ＊◇21. Bogdanova TI, Saenko VA, Hirokawa M, Ito M, Zurnadzhy LY, Hayashi T, Rogounovitch TI, Miyauchi A, Tronko MD,Yamashita S: Comparative histopathological analysis of sporadic pediatric papillary thyroid carcinoma from Japan and Ukraine.
Endocr J 64(10): 977-993, 2017. (IF: 1.837) ＊22. Takahashi H, Takahashi K, Shimura H, Yasumura S, Suzuki S, Ohtsuru A, Midorikawa S, Ohira T, Ohto H, Yamashita S,Kamiya K: Simulation of expected childhood and adolescent thyroid cancer cases in Japan using a cancer-progression model
based on the National Cancer Registry: Application to the first-round thyroid examination of the Fukushima Health Management
Survey. Medicine 96(48): e8631, 2017. (IF: 1.804) ＊23. Tsuchiya R, Taira Y, Orita M, Fukushima Y, Endo Y, Yamashita S, Takamura N: Radiocesium contamination and estimatedinternal exposure doses in edible wild plants in Kawauchi Village following the Fukushima nuclear disaster. PLoS One 12(12):e0189398, 2017. (IF: 2.806) ＊A-b
1. Yamashita S: Shigenobu Nagataki (January 18, 1932-Novemver 12, 2016). Thyroid 27(2): 135-136, 2017. (IF: 5.515) ＊A-e
1. Thomas G, Yamashita S: Thirty Years After Chernobyl and 5 After Fukushima ―What Have We Learnt and What Do We Still
Need to Know? In Thyroid Cancer and Nuclear Accidents (Yamashita S, Thomas G, eds., Elsevier) pp. xv-xxiv, 2017
2. Nagataki S, Yamashita S: Chapter 2 Thirty Years After the Chernobyl Nuclear Power Plant Accident: Contribution From Japan― “Confirming the Increase of Childhood Thyroid Cancer”. In Thyroid Cancer and Nuclear Accidents (Yamashita S, Thomas G,eds., Elsevier) pp.11-20, 2017
3. Demidchik YE, Fridman MV, Mankovskaya S, Krasko O, Schmid KW, Lam AK, Moiseev P, Saenko VA, Yamashita S: Chapter
5 Post-Chernobyl Pediatric Papillary Thyroid Carcinoma in Belarus: Histopathological Features, Treatments Strategy, andLong-Term Outcome. In Thyroid Cancer and Nuclear Accidents (Yamashita S, Gerry Thomas G, eds., Elsevier) pp.49-58, 2017
4. Bogdanova T, Saenko VA, Shpak V, Zurnadzhy L, Voskoboynyk L, Dekhtyarova T, Burko S, Gulii T, Yamashita S, Tronko M:
Chapter 7 Long-Term Analysis of the Incidence and Histopathology of Thyroid Cancer in Ukraine in Adult Patients Who Were
Children and Adolescents at the Time of the Chernobyl Accident. In Thyroid Cancer and Nuclear Accidents (Yamashita S,Thomas G, eds., Elsevier) pp.67-76, 2017
5. Ivanov V, Kashcheev V, Chekin S, Maksioutov M, Tumanov K, Menyajlo A, Vlasov O, Kochergina E, Kashcheeva P,Shchukina N, Korelo A, Seleva N, Galkin V, Kaprin A, Saenko VA, Yamashita S: Chapter 9 Results of the Thyroid Cancer
Epidemiological Survey in Russia Following the Chernobyl Accident. In Thyroid Cancer and Nuclear Accidents (Yamashita S,Thomas G, eds., Elsevier) pp.87-95, 2017
6. Ohtsuru A, Midorikawa S, Suzuki S, Shimura H, Matsuzuka T, Yamashita S: Chapter 14 Five-Year Interim Report of Thyroid
Ultrasound Examinations in the Fukushima Health Management Survey. In Thyroid Cancer and Nuclear Accidents (Yamashita S,Thomas G, eds., Elsevier) pp.145-153, 2017
7. Yamashita S: Radiation and Thyroid Cancer; lessons learned from Hiroshima, Nagasaki and Chernobyl to Fukushima. In
Forefront of Oncology Care: Discovery, Development and HTA (Proceedings of IAAO 2015, Chugai Academy for AdvancedOncology) pp100-115, 2017

B 邦文
B-b
1. Rogounovitch T, Saenko V: 甲状腺癌の素因となる一塩基多型：ゲノムワイド関連解析から得られた主な知見. ThyroidCancer Explore 3(1): 25-31, 2017
2. 光武範吏：甲状腺がんの遺伝子変異．最新医学 72 巻 10 号：78-84, 20172

3. 山下俊一：放射線と甲状腺 ―チェルノブイリと福島の事実から―．最新医学 72 巻 10 号：98-105, 2017
4. 山下俊一：放射線と健康影響. 臨床環境医学 26 巻 1 号: 1-6, 2017B-c
1. 鈴木啓司, 山下俊一： 3. 放射線防護の考え方と健康リスク. （「原子力年鑑」編集委員会編, 原子力年鑑 2018 Part
Ⅲ 福島を契機とした原子力発電をめぐる動向, 日刊工業新聞社, 東京, pp126-134） 2017B-e
1. 山下俊一：福島リポート 福島原発事故から 6 年 ―甲状腺検査の課題と今後. 日本医事新報 No.4846, 16-19, 2017
2. 山下俊一： 福島原発事故後の放射線リスクと社会の認知. 電気評論（特別寄稿）, 2017 年 9 月号
3. 岩澤康裕，福田裕穂，山川充夫，目黒公郎，岡田真美子，佐藤岩夫，廣瀬真理子，向井千秋，山下俊一，山本雅之，渡部終五，大久保修平，矢川元基，和田 章，佐藤慶一，沼田宗純（東日本大震災に係る学術調査検討委員会）：提言 東日本大震災に関する学術調査・研究活動 ―成果・課題・提案―．27 ページ，2017
4. 春日文子，池田眞朗，大塚孝治，杉田 敦，神谷研二，向井千秋，山下俊一，米倉義晴，大西 隆，伊香賀俊治，小森田秋夫，柴田德思，樋口輝彦，安村誠司，石井正己，石川広己，清水修二，瀬戸晥一（東日本大震災復興支援委員会原子力発電所事故に伴う健康影響評価と国民の健康管理並びに医療のあり方検討分科会）：提言 東日本大震災に伴う原発避難者の住民としての地位に関する提言．30 ページ，2017
5. 大西 隆，春日文子，杉田 敦，山下俊一，米倉義晴，池田眞朗，小森田秋夫，樋口輝彦，大塚孝治，柴田德思，瀬戸晥一，安村誠司，石井正三，清水修二，渡邊 明（東日本大震災復興支援委員会 原子力発電所事故に伴う健康影
響評価と国民の健康管理並びに医療のあり方検討分科会）：報告 東京電力福島第一原子力発電所事故被災者のためのより良い健康管理と医療の提供に向けて．41 ページ，2017
6. 山下俊一：更なる高みをめざして. 日本放射線影響学会 第 60 回大会記念文集：92-93, 2017
研究業績集計表

教 室 等 名 ： 503 放 射 線 災 害 医 療 学 研 究 分 野 （ 原 研 医 療 ）

論文数一覧
2017

A-aA-bA-cA-dA-e

合計

SCI

B-aB-bB-cB-dB-e

合計

総計2310073124041061142合計

総計

714

学会発表数一覧
A-bA-a2017

合計

ｼﾝﾎﾟｼﾞｳﾑ学会

2057B-bB-a

ｼﾝﾎﾟｼﾞｳﾑ

学会

214

論文総数に係る教員生産係数一覧

2017

欧文論文総数
論文総数

教員生産係数（欧文論文）

SCI掲載論文数
欧文論文総数

教員生産係数（SCI掲載論文）

0.738

10.3330.774

8Impact factor 値一覧
2017

Impact factor

教員当たり Impact factor

論文当たり Impact factor

80.97626.9923.3743